These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30541577)

  • 41. Harm reduction in U.S. tobacco control: Constructions in textual news media.
    Eversman MH
    Int J Drug Policy; 2015 Jun; 26(6):575-82. PubMed ID: 25727451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes.
    Pulvers K; Emami AS; Nollen NL; Romero DR; Strong DR; Benowitz NL; Ahluwalia JS
    Nicotine Tob Res; 2018 Jan; 20(2):206-214. PubMed ID: 28003511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993.
    Cummings KM; Hyland A; Ockene JK; Hymowitz N; Manley M
    Tob Control; 1997; 6 Suppl 2(Suppl 2):S63-70. PubMed ID: 9583655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strategies for smoking cessation: what is new and what works?
    Cummings KM; Mahoney MC
    Expert Rev Respir Med; 2008 Apr; 2(2):201-13. PubMed ID: 20477249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus Nicotine Replacement Therapy.
    Balfour L; Wiebe SA; Cameron WD; Sandre D; Pipe A; Cooper C; Angel J; Garber G; Holly C; Dalgleish TL; Tasca GA; MacPherson PA
    AIDS Care; 2017 Jan; 29(1):24-31. PubMed ID: 27435835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.
    Smith TT; Hatsukami DK; Benowitz NL; Colby SM; McClernon FJ; Strasser AA; Tidey JW; White CM; Donny EC
    Prev Med; 2018 Dec; 117():8-14. PubMed ID: 29604326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2.
    Martin F; Talikka M; Ivanov NV; Haziza C; Hoeng J; Peitsch MC
    Regul Toxicol Pharmacol; 2016 Nov; 81 Suppl 2():S151-S157. PubMed ID: 27845159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.
    Ghura S; Gross R; Jordan-Sciutto K; Dubroff J; Schnoll R; Collman RG; Ashare RL
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):694-714. PubMed ID: 31834620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Harm reduction for smokers living with HIV.
    Shuter J; Reddy KP; Hyle EP; Stanton CA; Rigotti NA
    Lancet HIV; 2021 Oct; 8(10):e652-e658. PubMed ID: 34461050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The New Nicotine Pouch Category: A Tobacco Harm Reduction Tool?
    Patwardhan S; Fagerström K
    Nicotine Tob Res; 2022 Mar; 24(4):623-625. PubMed ID: 34606613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Creating Standardized Tools for the Pharmacist-Led Assessment and Pharmacologic Management of Adult Canadians Wishing to Quit Smoking: A Consensus-Based Approach.
    Butt K; Nakhla N
    Pharmacy (Basel); 2021 Apr; 9(2):. PubMed ID: 33919918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients are asking about e-cigarettes. What do we tell them?
    Worsley DJ; Jones K; Marshman Z
    Br Dent J; 2014 Jul; 217(2):91-5. PubMed ID: 25060461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for the Appropriate Structure, Communication, and Investigation of Tobacco Harm Reduction Claims. An Official American Thoracic Society Policy Statement.
    Leone FT; Carlsen KH; Chooljian D; Crotty Alexander LE; Detterbeck FC; Eakin MN; Evers-Casey S; Farber HJ; Folan P; Kathuria H; Latzka K; McDermott S; McGrath-Morrow S; Moazed F; Munzer A; Neptune E; Pakhale S; Sachs DPL; Samet J; Sufian B; Upson D
    Am J Respir Crit Care Med; 2018 Oct; 198(8):e90-e105. PubMed ID: 30320525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tobacco Harm Reduction as a Path to Restore Trust in Tobacco Control.
    Antin TMJ; Hunt G; Annechino R
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34067476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tobacco use, attitudes and cessation practices among healthcare workers of a city health department in Southern India.
    Mony PK; Vishwanath NS; Krishnan S
    J Family Med Prim Care; 2015; 4(2):261-4. PubMed ID: 25949978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introducing oral tobacco for tobacco harm reduction: what are the main obstacles?
    Martinet Y; Bohadana A; Fagerström K
    Harm Reduct J; 2007 Nov; 4():17. PubMed ID: 17988383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of Harm Reduction Kits in a Specialty HIV Hospital.
    Miskovic M; Chan Carusone S; Guta A; O'Leary B; dePrinse K; Strike C
    Am J Public Health; 2018 Oct; 108(10):1363-1365. PubMed ID: 30138074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Harm Reduction Ethics, Public Health, and the Manufacture of Doubt.
    Goldberg DS
    Am J Bioeth; 2022 Oct; 22(10):18-20. PubMed ID: 36170068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.